Proactive Investors - Run By Investors For Investors

LeanLife Health names Jason Tong as new finance chief

Tong is currently the finance chief at ExGen Resources and is a senior advisor to several companies
A boardroom
Tong was appointed as chief financial officer following the resignation of Casey Forward

LeanLife Health Inc (CSE:LLP) unveiled some board changes, including the appointment of experienced executive Jason Tong as the group's new finance chief.

He was appointed as chief financial officer following the resignation on January 9 of Casey Forward who stepped down due to health reasons.

READ: LeanLife Health to benefit from Canada’s sweeping new food safety rules

Tong is currently the finance chief at ExGen Resources and is a senior advisor to several high- growth companies.

He has served in senior management roles for a number of public and private companies and was previously the chief financial officer of Pathway Capital Ltd, a venture capital group with a portfolio of early-stage ventures with market caps ranging from $5 million to $100 million.

He was also CFO at Turnberry Resources Ltd from February 2012 until it was acquired in April 2014.

Also in the statement, LeanLife said shareholders had voted in favour of all resolutions at its AGM on January 4 this year.

Vancouver-based LeanLife has developed a patented process to isolate omega 3 fatty acids from flax (linen) seeds — one of the richest plant sources of this essential fatty acid.

Contact Giles at [email protected]

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

Once the phase III trial is completed, Futura plans to either sell off the asset or find a partner
September 26 2018
The pharma group expects to dose the first patient in the Phase III trial of its MED2002 erectile dysfunction treatment within the next month
Lung X-Ray
October 22 2018
In its recent half-year results, the medical research investor recorded a loss after tax of £4.6mln in the six months ended June 30, less than the £5.2mln loss a year ago
porcupine
November 30 2018
It’s been a tricky period for Redx, but it has come through it with a promising pipeline, cash in the bank and AstraZeneca’s former UK boss as its new chief executive
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use